News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
751,862 Results
Type
Article (48845)
Company Profile (324)
Press Release (702675)
Multimedia
Podcasts (108)
Webinars (23)
Section
Business (210543)
Career Advice (2237)
Deals (36278)
Drug Delivery (140)
Drug Development (82956)
Employer Resources (197)
FDA (16717)
Job Trends (15430)
News (355200)
Policy (33572)
Tag
2027 BioCapital Elite (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2787)
Academic (2)
Accelerated approval (42)
Adcomms (28)
Allergies (162)
Alliances (51316)
ALS (196)
Alzheimer's disease (1798)
Antibody-drug conjugate (ADC) (375)
Approvals (17021)
Artificial intelligence (636)
Autoimmune disease (227)
Automation (51)
Bankruptcy (369)
Best Places to Work (11883)
BIOSECURE Act (21)
Biosimilars (206)
Biotechnology (204)
Bladder cancer (178)
Brain cancer (63)
Breast cancer (696)
Cancer (5385)
Cardiovascular disease (451)
Career advice (1904)
Career pathing (44)
CAR-T (312)
CDC (59)
Celiac Disease (2)
Cell therapy (828)
Cervical cancer (42)
Clinical research (71132)
Collaboration (1973)
Company closure (4)
Compensation (1274)
Complete response letters (71)
COVID-19 (2808)
CRISPR (102)
C-suite (1022)
Cystic fibrosis (149)
Data (7107)
Decentralized trials (3)
Denatured (41)
Depression (157)
Dermatology (57)
Diabetes (553)
Diagnostics (7055)
Digital health (52)
Diversity (13)
Diversity, equity & inclusion (48)
Drug discovery (312)
Drug pricing (205)
Drug shortages (30)
Duchenne muscular dystrophy (271)
Earnings (92072)
Editorial (64)
Employer branding (25)
Employer resources (167)
Events (122459)
Executive appointments (1077)
FDA (20175)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (29)
Funding (1679)
Gene editing (220)
Generative AI (58)
Gene therapy (684)
GLP-1 (1064)
Government (4880)
Grass and pollen (6)
Guidances (397)
Healthcare (19471)
HIV (74)
Huntington's disease (55)
IgA nephropathy (93)
Immunology and inflammation (281)
Immuno-oncology (81)
Indications (157)
Infectious disease (3125)
Inflammatory bowel disease (209)
Inflation Reduction Act (16)
Influenza (129)
Intellectual property (278)
Interviews (357)
IPO (16896)
IRA (52)
Job creations (3865)
Job search strategy (1594)
JPM (62)
Kidney cancer (18)
Labor market (101)
Layoffs (583)
Leadership (39)
Legal (8126)
Liver cancer (100)
Longevity (29)
Lung cancer (724)
Lymphoma (409)
Machine learning (53)
Management (63)
Manufacturing (945)
MASH (181)
Medical device (14123)
Medtech (14203)
Mergers & acquisitions (20547)
Metabolic disorders (1439)
mRNA (181)
Multiple sclerosis (175)
NASH (23)
Neurodegenerative disease (397)
Neuropsychiatric disorders (99)
Neuroscience (3222)
Neurotech (1)
NextGen: Class of 2026 (6787)
Non-profit (4738)
Now hiring (74)
Obesity (684)
Opinion (303)
Ovarian cancer (188)
Pain (233)
Pancreatic cancer (256)
Parkinson's disease (345)
Partnered (35)
Patents (558)
Patient recruitment (595)
Peanut (62)
People (61644)
Pharmaceutical (69)
Pharmacy benefit managers (32)
Phase 1 (22180)
Phase 2 (31301)
Phase 3 (23318)
Pipeline (7158)
Policy (319)
Postmarket research (2651)
Preclinical (9632)
Press Release (72)
Prostate cancer (276)
Psychedelics (52)
Radiopharmaceuticals (309)
Rare diseases (1012)
Real estate (6313)
Recruiting (77)
Regulatory (25525)
Reports (70)
Research institute (2574)
Resumes & cover letters (380)
Rett syndrome (32)
RNA editing (18)
RSV (87)
Schizophrenia (168)
Series A (284)
Series B (207)
Service/supplier (13)
Sickle cell disease (110)
Special edition (25)
Spinal muscular atrophy (167)
Sponsored (46)
Startups (3851)
State (2)
Stomach cancer (19)
Supply chain (120)
Tariffs (85)
The Weekly (65)
Vaccines (1097)
Venture capital (103)
Weight loss (441)
Women's health (111)
Worklife (21)
Date
Last 7 days (651)
Last 30 days (2473)
Last 365 days (30540)
2026 (8158)
2025 (30861)
2024 (36076)
2023 (40996)
2022 (52063)
2021 (56682)
2020 (55087)
2019 (47936)
2018 (36164)
2017 (33199)
2016 (32818)
2015 (38897)
2014 (32511)
2013 (27656)
2012 (29895)
2011 (30617)
2010 (29115)
Location
Africa (816)
Alabama (94)
Alaska (7)
Arizona (342)
Arkansas (14)
Asia (41417)
Australia (6805)
California (12400)
Canada (3541)
China (1245)
Colorado (532)
Connecticut (525)
Delaware (369)
Europe (90645)
Florida (1859)
Georgia (408)
Hawaii (4)
Idaho (63)
Illinois (976)
India (83)
Indiana (571)
Iowa (23)
Japan (496)
Kansas (132)
Kentucky (46)
Louisiana (40)
Maine (73)
Maryland (1498)
Massachusetts (8930)
Michigan (370)
Minnesota (701)
Mississippi (7)
Missouri (140)
Montana (33)
Nebraska (29)
Nevada (138)
New Hampshire (85)
New Jersey (3330)
New Mexico (31)
New York (3293)
North Carolina (1622)
North Dakota (10)
Northern California (6118)
Ohio (371)
Oklahoma (23)
Oregon (42)
Pennsylvania (2504)
Puerto Rico (26)
Rhode Island (50)
South America (1194)
South Carolina (76)
South Dakota (1)
Southern California (4864)
Tennessee (203)
Texas (1967)
United States (44191)
Utah (373)
Vermont (1)
Virginia (308)
Washington D.C. (85)
Washington State (997)
West Virginia (4)
Wisconsin (135)
Wyoming (2)
751,862 Results for "vision sciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Texas Healthcare and Bioscience Institute Releases Strategic Vision to Advance the Texas Life Sciences Ecosystem
March 30, 2026
·
3 min read
Press Releases
Nanoscope Therapeutics Announces Publication of New Study Highlighting Functional Vision Assessment in Retinal Disease
March 23, 2026
·
4 min read
Press Releases
Viatris to Outline its Vision for Sustained Revenue and Earnings Growth Through 2030
March 19, 2026
·
19 min read
Press Releases
BioRegenx, Inc. (OTC: BRGX) Announces Major Corporate Progress, Auditor Transition, Technology Integration, and AI-Driven Strategic Vision
December 10, 2025
·
5 min read
Press Releases
BioMark: 2025 Achievements & 2026 Vision
Celebrating A Year of Extraordinary Achievement
January 2, 2026
·
7 min read
Press Releases
Driven by a common vision, Mochida Pharmaceutical Co., Ltd. and Duchesnay Inc. sign a partnership to help address the issue of drug gap in Japan
December 15, 2025
·
3 min read
Press Releases
Sanaregen™ Vision Therapeutics Receives FDA Clearance for Clinical Trial to Treat Retinal Degeneration
March 3, 2026
·
2 min read
Press Releases
Nanoscope Therapeutics Receives Orphan Drug Designation in Saudi Arabia for MCO-010, Expands Global Regulatory Leadership in Vision Restoration
March 30, 2026
·
4 min read
Press Releases
Ministerial Visit to Athlone Laboratories: A Vision for the Future of Critical Medicines in Ireland
March 9, 2026
·
1 min read
Press Releases
BioSyent Announces Closing of the Acquisition of Oral Science Inc.
March 2, 2026
·
3 min read
1 of 75,187
Next
